Back
Renalytix PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
12
RNLX
Renalytix PLC
Last Price:
0.51
Seasonality Move:
-10.17%
Buy
55
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.10
Seasonality Move:
-1.36%
Sell
12
Renalytix PLC (RNLX)
is a Sell
Is Renalytix PLC a Buy, Sell or Hold?
- The current Renalytix PLC [RNLX] share price is $0.51. The Score for RNLX is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- RNLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.11. The Score for ADAP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RNLX Stock Price Chart
What is Renalytix PLC's stock price today?
-
The Renalytix PLC share price today is $0.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNLX is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
RNLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 33.62 | Sell |
| Chaikin Money Flow: | -350087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.78) | Sell |
| Bollinger Bands (100): | (0.4 - 0.98) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 44.73 | Sell |
| Chaikin Money Flow: | -768979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.19) | Buy |
| Bollinger Bands (100): | (0.89 - 1.47) | Sell |
RNLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.61 | Sell |
| 20-day SMA: | 0.66 | Sell |
| 50-day SMA: | 0.79 | Sell |
| 200-day SMA: | 1.1 | Sell |
| 8-day EMA: | 0.6 | Sell |
| 20-day EMA: | 0.66 | Sell |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 1.16 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.16 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.19 | Sell |
| 200-day EMA: | 1.09 | Buy |
Renalytix PLC Earnings Growth & RNLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.05 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
Renalytix PLC Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||